Immediate Impact
52 standout
Citing Papers
Hepatocellular carcinoma: signaling pathways and therapeutic advances
2025 Standout
EASL Clinical Practice Guidelines on the management of hepatitis B virus infection
2025 Standout
Works of Xu–Ting Zhi being referenced
Clinical Benefit of Antiviral Agents for Hepatocellular Carcinoma Patients With Low Preoperative HBV-DNA Loads Undergoing Curative Resection: A Meta-Analysis
2021
TMPRSS4 Drives Angiogenesis in Hepatocellular Carcinoma by Promoting HB‐EGF Expression and Proteolytic Cleavage
2019
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Xu–Ting Zhi | 131 | 141 | 96 | 229 | 185 | 31 | 529 | |
| Bei‐Ge Jiang | 162 | 134 | 109 | 301 | 211 | 26 | 629 | |
| Zhiyong Du | 205 | 212 | 100 | 306 | 186 | 36 | 649 | |
| Jihong Ma | 72 | 87 | 107 | 281 | 119 | 24 | 523 | |
| Sakiko Sanada | 125 | 196 | 70 | 159 | 101 | 29 | 490 | |
| Ru Ji | 98 | 182 | 77 | 270 | 146 | 17 | 539 | |
| Songtao Lai | 92 | 246 | 55 | 301 | 159 | 21 | 613 | |
| Xuan Meng | 127 | 139 | 49 | 203 | 101 | 27 | 482 | |
| Imane El Dika | 79 | 212 | 172 | 203 | 141 | 30 | 560 | |
| Zhibo Xie | 73 | 199 | 67 | 200 | 126 | 24 | 497 | |
| Amane Takahashi | 113 | 179 | 115 | 213 | 161 | 36 | 572 |
All Works
Login with ORCID to disown or claim papers
Loading papers...